• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX

TELIX PHARMACEUTICALS LIMITED - Charts / Financials

2.05% ! $18.20
Market Cap $6.158B  !

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 07/08/2025 (20 minute delay) ?
Day
Open $18.35   Day High $18.51   Day Low $17.80
Daily Volume 2917367
Bids   Sellers
Number Price Volume   Number Price Volume
1 $18.18 200   1 $18.21 54

Directors & Senior Management

Dr. Christian P. Behrenbruch Group Chief Executive Officer, Managing Director, Executive Director
Mr. Darren Smith Group Chief Financial Officer
Mr. Raphaeel Ortiz Chief Executive Officer - Telix International
Mr. Kevin Richardson Chief Executive Officer - Telix Precision Medicine
Dr. Darren Patti Group Chief Operating Officer
Dr. Paul Schaffer Chief Technology Officer
Ms. Lena Moran-Adams Group General Counsel
Dr. David Cade Group Chief Medical Officer
Mr. James Stonecypher Group Chief Development Officer
Mr. Richard Valeix Group Chief Commercial Officer
Ms. Tiffany P. Olson Non-Executive Independent Chairman of the Board
Ms. Marie McDonald Non-Executive Director
Dr. Mark Nelson Non-Executive Independent Director
Ms. Jann Skinner Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$18.20
Change
-0.380(2.05%)
Mkt cap ! $6.158B
Open High Low Value Volume
$18.35 $18.51 $17.80 $52.74M 2.917M

Buyers (Bids)

No. Vol. Price($)
1 200 $18.18
 

Sellers (Offers)

Price($) Vol. No.
$18.21 54 1
View Market Depth
Last trade - 16.19pm 07/08/2025 (20 minute delay) ?
Last
$18.18
  Change
-0.380 ( 1.95 %)
Open High Low Volume
$18.45 $18.51 $17.80 388999
Last updated 15.59pm 07/08/2025 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.